Elicio Therapeutics Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$8.32

+0.71 (+9.33%)

As of Feb 8, 2:08 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +285.1% upside

Low Target $22.50

Average Target $32.04

High Target $35.39

Current Price $8.32

Current
$8.32

Target
$32.04

$22.50 $32.04 avg $35.39

Scenario Analysis

Bear Case

$22.50

170.4%

Low target

Base Case

$32.04

+285.1%

Avg target

Bull Case

$35.39

+325.4%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$33.53

-75.2% from high

52-Week Low

$19.74

+-57.9% from low

Target vs 52W High

$32.04

-4.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%